EPC-K1

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H466132

CAS#: 127061-56-7 (potassium)

Description: EPC-K1 is a Vitamin E derivative, suppressing inflammation during hepatic ischemia-reperfusion injury and exerting hepatoprotective effects.


Chemical Structure

img
EPC-K1
CAS# 127061-56-7 (potassium)

Theoretical Analysis

Hodoodo Cat#: H466132
Name: EPC-K1
CAS#: 127061-56-7 (potassium)
Chemical Formula: C35H56KO10P
Exact Mass: 706.32
Molecular Weight: 706.895
Elemental Analysis: C, 59.47; H, 7.99; K, 5.53; O, 22.63; P, 4.38

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: EPC-K1; EPCK1; EPC K1; Potassium ascorbyl tocopheryl phosphate;

IUPAC/Chemical Name: potassium (R)-5-((S)-1,2-dihydroxyethyl)-4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl ((R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-yl) phosphate

InChi Key: VIHIKSJKXIMMLV-FZTHFCCHSA-M

InChi Code: InChI=1S/C35H57O10P.K/c1-21(2)12-9-13-22(3)14-10-15-23(4)16-11-18-35(8)19-17-27-26(7)30(24(5)25(6)31(27)43-35)44-46(40,41)45-33-29(38)32(28(37)20-36)42-34(33)39;/h21-23,28,32,36-38H,9-20H2,1-8H3,(H,40,41);/q;+1/p-1/t22-,23-,28+,32-,35-;/m1./s1

SMILES Code: O=P(OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O)([O-])OC2=C(C)C(CC[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)O3)=C3C(C)=C2C.[K+]

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 706.90 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Zingg JM, Azzi A, Meydani M. α-Tocopheryl Phosphate Induces VEGF Expression via CD36/PI3Kγ in THP-1 Monocytes. J Cell Biochem. 2017 Jul;118(7):1855-1867. doi: 10.1002/jcb.25871. Epub 2017 Mar 24. PMID: 28059487.

2: Zhao L, Zhao X, Zhao K, Wei P, Fang Y, Zhang F, Zhang B, Ogata K, Mori A, Wei T. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism. Eur J Pharmacol. 2014 Dec 15;745:98-107. doi: 10.1016/j.ejphar.2014.09.050. Epub 2014 Oct 15. PMID: 25446928.

3: Hara T, Matsui H, Shimizu H. Suppression of microbial metabolic pathways inhibits the generation of the human body odor component diacetyl by Staphylococcus spp. PLoS One. 2014 Nov 12;9(11):e111833. doi: 10.1371/journal.pone.0111833. PMID: 25390046; PMCID: PMC4229079.

4: Oishi K, Hagiwara S, Koga S, Kawabe S, Uno T, Iwasaka H, Noguchi T. The vitamin E derivative, EPC-K1, suppresses inflammation during hepatic ischemia- reperfusion injury and exerts hepatoprotective effects in rats. J Surg Res. 2012 Jul;176(1):164-70. doi: 10.1016/j.jss.2011.03.080. Epub 2011 Apr 28. PMID: 22560539.

5: Yamamoto S, Hagiwara S, Hidaka S, Shingu C, Goto K, Kashima K, Noguchi T. The antioxidant EPC-K1 attenuates renal ischemia-reperfusion injury in a rat model. Am J Nephrol. 2011;33(6):485-90. doi: 10.1159/000327820. Epub 2011 May 3. PMID: 21540580.

6: Chang WJ, Toledo-Pereyra LH. Importance of EPC-K1 in ischemia and reperfusion injury. J Surg Res. 2011 Jun 15;168(2):173-4. doi: 10.1016/j.jss.2010.06.027. Epub 2010 Sep 8. PMID: 20850788.

7: Noda Y, Mankura M. Inhibitory effect of antioxidants on hydroxyl radical generation from methylguanidine: an ESR study. Neurochem Res. 2009 Apr;34(4):734-8. doi: 10.1007/s11064-008-9811-9. Epub 2008 Aug 8. PMID: 18688710.

8: Mundy AL, Haas E, Bhattacharya I, Widmer CC, Kretz M, Baumann K, Barton M. Endothelin stimulates vascular hydroxyl radical formation: effect of obesity. Am J Physiol Regul Integr Comp Physiol. 2007 Dec;293(6):R2218-24. doi: 10.1152/ajpregu.00295.2007. Epub 2007 Sep 26. PMID: 17898123.

9: Munteanu A, Zingg JM. Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol Aspects Med. 2007 Oct-Dec;28(5-6):538-90. doi: 10.1016/j.mam.2007.07.001. Epub 2007 Aug 3. PMID: 17825403.

10: Nishi H, Date H, Aoe M, Shimizu N. Canine bilateral lung transplantation after 18-hour preservation using non-heart-beating donors. J Heart Lung Transplant. 2007 Jun;26(6):610-6. doi: 10.1016/j.healun.2007.03.013. PMID: 17543785.

11: Shirai S, Ominato M, Shimazu T, Toyama K, Ogimoto G, Fujino T, Yasuda T, Sato T, Maeba T, Owada S, Kimura K. Imbalance between production and scavenging of hydroxyl radicals in patients maintained on hemodialysis. Clin Exp Nephrol. 2005 Dec;9(4):310-314. doi: 10.1007/s10157-005-0374-7. PMID: 16362158.

12: Hirai T, Matsumoto H, Yamashita K, Urakami A, Iki K, Yamamura M, Tsunoda T. Surgical oncotaxis--excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients. Ann Thorac Cardiovasc Surg. 2005 Feb;11(1):4-6. PMID: 15788961.

13: Mori A, Yokoi I, Noda Y, Willmore LJ. Natural antioxidants may prevent posttraumatic epilepsy: a proposal based on experimental animal studies. Acta Med Okayama. 2004 Jun;58(3):111-8. doi: 10.18926/AMO/32111. PMID: 15471432.

14: Kingston R, Kelly CJ, Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr Pharm Des. 2004;10(19):2401-10. doi: 10.2174/1381612043384015. PMID: 15279617.

15: Irie H, Kato T, Ikebe K, Tsuchida T, Oniki Y, Takagi K. Antioxidant effect of MCI-186, a new Free-Radical scavenger, on ischemia-reperfusion injury in a rat hindlimb amputation model. J Surg Res. 2004 Aug;120(2):312-9. doi: 10.1016/j.jss.2003.12.004. PMID: 15234228.

16: Kozuka M, Tsujimoto Y. Dentin is dissolved by high concentrations of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)- 2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt with or without hydrogen peroxide. Biol Pharm Bull. 2004 Jun;27(6):831-4. doi: 10.1248/bpb.27.831. PMID: 15187428.

17: Takayama H, Hamner CE, Caccitolo JA, Hisamochi K, Pearson PJ, Schaff HV. A novel antioxidant, EPC-K1, stimulates endothelial nitric oxide production and scavenges hydroxyl radicals. Circ J. 2003 Dec;67(12):1046-52. doi: 10.1253/circj.67.1046. PMID: 14639022.

18: Kato N, Yanaka K, Nagase S, Hirayama A, Nose T. The antioxidant EPC-K1 ameliorates brain injury by inhibiting lipid peroxidation in a rat model of transient focal cerebral ischaemia. Acta Neurochir (Wien). 2003 Jun;145(6):489-93; discussion 493. doi: 10.1007/s00701-003-0036-z. PMID: 12836074.

19: Zondlo Fiume M. Final report on the safety assessment of Tocopherol, Tocopheryl Acetate, Tocopheryl Linoleate, Tocopheryl Linoleate/Oleate, Tocopheryl Nicotinate, Tocopheryl Succinate, Dioleyl Tocopheryl Methylsilanol, Potassium Ascorbyl Tocopheryl Phosphate, and Tocophersolan. Int J Toxicol. 2002;21 Suppl 3:51-116. doi: 10.1080/10915810290169819. PMID: 12537931.

20: Matsuo K, Mori S, Ijichi T, Nakajima K, Kokufu T, Ihara N. EPC-K1 reduces the expression of inducible nitric oxide synthase (iNOS) in delayed neuronal death (DND). Ann N Y Acad Sci. 2002 Nov;977:292-5. doi: 10.1111/j.1749-6632.2002.tb04828.x. PMID: 12480763.